Aspirin resistance in cardiovascular disease
- PMID: 18202035
- PMCID: PMC2213790
- DOI: 10.1136/bmj.39405.635498.80
Aspirin resistance in cardiovascular disease
Abstract
Carries a worse prognosis, but may be indicative of pre-existing higher risk
Conflict of interest statement
Competing interests:GB-Z has received lecture fees from Bristol-Myers Squibb.
Comment on
-
Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis.BMJ. 2008 Jan 26;336(7637):195-8. doi: 10.1136/bmj.39430.529549.BE. Epub 2008 Jan 17. BMJ. 2008. PMID: 18202034 Free PMC article.
References
-
- Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008. doi: 10.1136/bmj.39430.529549.BE. - PMC - PubMed
-
- Campo G, Valgimigli M, Gemmati D, Percoco G, Catozzi L, Frangione A, et al. Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study. J Am Coll Cardiol 2007;50:1132-7. - PubMed
-
- Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28:1702-8. - PubMed
-
- Barnes GD, Li J, Kline-Rogers E, Vedre A, Armstrong DF, Froehlich JB, et al. Dual antiplatelet agent failure: a new syndrome or clinical nonentity? Am Heart J 2007;154:732-5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical